Literature DB >> 26824662

Parsing the Interferon Transcriptional Network and Its Disease Associations.

Sara Mostafavi1, Hideyuki Yoshida2, Devapregasan Moodley2, Hugo LeBoité2, Katherine Rothamel2, Towfique Raj3, Chun Jimmie Ye4, Nicolas Chevrier5, Shen-Ying Zhang6, Ting Feng2, Mark Lee4, Jean-Laurent Casanova6, James D Clark7, Martin Hegen7, Jean-Baptiste Telliez7, Nir Hacohen4, Philip L De Jager3, Aviv Regev4, Diane Mathis8, Christophe Benoist8.   

Abstract

Type 1 interferon (IFN) is a key mediator of organismal responses to pathogens, eliciting prototypical "interferon signature genes" that encode antiviral and inflammatory mediators. For a global view of IFN signatures and regulatory pathways, we performed gene expression and chromatin analyses of the IFN-induced response across a range of immunocyte lineages. These distinguished ISGs by cell-type specificity, kinetics, and sensitivity to tonic IFN and revealed underlying changes in chromatin configuration. We combined 1,398 human and mouse datasets to computationally infer ISG modules and their regulators, validated by genetic analysis in both species. Some ISGs are controlled by Stat1/2 and Irf9 and the ISRE DNA motif, but others appeared dependent on non-canonical factors. This regulatory framework helped to interpret JAK1 blockade pharmacology, different clusters being affected under tonic or IFN-stimulated conditions, and the IFN signatures previously associated with human diseases, revealing unrecognized subtleties in disease footprints, as affected by human ancestry.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26824662      PMCID: PMC4743492          DOI: 10.1016/j.cell.2015.12.032

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  42 in total

1.  Biologic consequences of Stat1-independent IFN signaling.

Authors:  M P Gil; E Bohn; A K O'Guin; C V Ramana; B Levine; G R Stark; H W Virgin; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

Review 2.  Mechanisms of type-I interferon signal transduction.

Authors:  Shahab Uddin; Leonidas C Platanias
Journal:  J Biochem Mol Biol       Date:  2004-11-30

Review 3.  Complex modulation of cell type-specific signaling in response to type I interferons.

Authors:  Anette H H van Boxel-Dezaire; M R Sandhya Rani; George R Stark
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

4.  Interferon alpha activates the tyrosine kinase Lyn in haemopoietic cells.

Authors:  S Uddin; I M Grumbach; T Yi; O R Colamonici; L C Platanias
Journal:  Br J Haematol       Date:  1998-06       Impact factor: 6.998

Review 5.  Type I interferons (alpha/beta) in immunity and autoimmunity.

Authors:  Argyrios N Theofilopoulos; Roberto Baccala; Bruce Beutler; Dwight H Kono
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

6.  Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity.

Authors:  Benjamin R Tenoever; Sze-Ling Ng; Mark A Chua; Sarah M McWhirter; Adolfo García-Sastre; Tom Maniatis
Journal:  Science       Date:  2007-03-02       Impact factor: 47.728

7.  The transition between transcriptional initiation and elongation in E. coli is highly variable and often rate limiting.

Authors:  Nikos B Reppas; Joseph T Wade; George M Church; Kevin Struhl
Journal:  Mol Cell       Date:  2006-12-08       Impact factor: 17.970

8.  Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo.

Authors:  Ariane Chapgier; Robert F Wynn; Emmanuelle Jouanguy; Orchidée Filipe-Santos; Shenying Zhang; Jacqueline Feinberg; Kay Hawkins; Jean-Laurent Casanova; Peter D Arkwright
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

9.  A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity.

Authors:  Michael H Shaw; Victor Boyartchuk; Sandy Wong; Marina Karaghiosoff; Josiane Ragimbeau; Sandra Pellegrini; Mathias Muller; William F Dietrich; George S Yap
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-18       Impact factor: 11.205

10.  Functional role of type I and type II interferons in antiviral defense.

Authors:  U Müller; U Steinhoff; L F Reis; S Hemmi; J Pavlovic; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

View more
  99 in total

Review 1.  Transcriptional and chromatin regulation in interferon and innate antiviral gene expression.

Authors:  Nancy Au-Yeung; Curt M Horvath
Journal:  Cytokine Growth Factor Rev       Date:  2018-10-22       Impact factor: 7.638

Review 2.  Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics.

Authors:  Romain Banchereau; Alma-Martina Cepika; Jacques Banchereau; Virginia Pascual
Journal:  Annu Rev Immunol       Date:  2017-01-30       Impact factor: 28.527

3.  Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment.

Authors:  Kanstantsin V Katlinski; Jun Gui; Yuliya V Katlinskaya; Angelíca Ortiz; Riddhita Chakraborty; Sabyasachi Bhattacharya; Christopher J Carbone; Daniel P Beiting; Melanie A Girondo; Amy R Peck; Ellen Puré; Priya Chatterji; Anil K Rustgi; J Alan Diehl; Constantinos Koumenis; Hallgeir Rui; Serge Y Fuchs
Journal:  Cancer Cell       Date:  2017-02-13       Impact factor: 31.743

4.  The IFN Response in Bats Displays Distinctive IFN-Stimulated Gene Expression Kinetics with Atypical RNASEL Induction.

Authors:  Pamela C De La Cruz-Rivera; Mohammed Kanchwala; Hanquan Liang; Ashwani Kumar; Lin-Fa Wang; Chao Xing; John W Schoggins
Journal:  J Immunol       Date:  2017-11-27       Impact factor: 5.422

Review 5.  Host-Intrinsic Interferon Status in Infection and Immunity.

Authors:  Beiyun C Liu; Joseph Sarhan; Alexander Poltorak
Journal:  Trends Mol Med       Date:  2018-07-07       Impact factor: 11.951

Review 6.  Too much of a good thing: Detrimental effects of interferon.

Authors:  Nancy C Reich
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

7.  Network pharmacology of JAK inhibitors.

Authors:  Devapregasan Moodley; Hideyuki Yoshida; Sara Mostafavi; Natasha Asinovski; Adriana Ortiz-Lopez; Peter Symanowicz; Jean-Baptiste Telliez; Martin Hegen; James D Clark; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-11       Impact factor: 11.205

8.  Open-source ImmGen: mononuclear phagocytes.

Authors: 
Journal:  Nat Immunol       Date:  2016-06-21       Impact factor: 25.606

9.  The Transcription Factor T-bet Limits Amplification of Type I IFN Transcriptome and Circuitry in T Helper 1 Cells.

Authors:  Shigeru Iwata; Yohei Mikami; Hong-Wei Sun; Stephen R Brooks; Dragana Jankovic; Kiyoshi Hirahara; Atsushi Onodera; Han-Yu Shih; Takeshi Kawabe; Kan Jiang; Toshinori Nakayama; Alan Sher; John J O'Shea; Fred P Davis; Yuka Kanno
Journal:  Immunity       Date:  2017-06-13       Impact factor: 31.745

10.  JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome.

Authors:  Kathryn D Tuttle; Katherine A Waugh; Paula Araya; Ross Minter; David J Orlicky; Michael Ludwig; Zdenek Andrysik; Matthew A Burchill; Beth A J Tamburini; Colin Sempeck; Keith Smith; Ross Granrath; Dayna Tracy; Jessica Baxter; Joaquin M Espinosa; Kelly D Sullivan
Journal:  Cell Rep       Date:  2020-11-17       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.